Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoth, P. E. M.
Right arrow Articles by Wolters, E. Ch.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoth, P. E. M.
Right arrow Articles by Wolters, E. Ch.
NEUROLOGY 1987;37:1214
© 1987 American Academy of Neurology

Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis

Patrick E. M. Schoth, MD and Erik Ch. Wolters, MD

Department of Neurology, Free University Hospital, Amsterdam, The Netherlands.

Eight neurosyphilitic patients (two asymptomatic, six symptomatic) were treated with intravenously administered aqueous penicillin G, 0.15 million IU/kg body weight/24 hrs for 15 days. On the 8th day of treatment, penicillin concentrations were determined in serum and CSF samples collected at hourly intervals over a period of 8 hours, using a microbiological assay method. Serum concentrations ranged from 0.26 to 100 mg/l, while CSF concentrations ranged from 0.062 to 3.0 mg/l. These results indicate that, by ensuring penicillin concentrations in CSF, which are continuously above the minimal fully treponemicidal concentration during the course of treatment, this treatment regimen should provide an adequate therapy for asymptomatic and symptomatic neurosyphilis.

Address correspondence and reprint requests to Dr. Schoth, Department of Neurology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Received July 1, 1986. Accepted for publication in final form October 24, 1986.




This article has been cited by other articles:


Home page
 Int J STD AIDSHome page
P French, M Gomberg, M Janier, B Schmidt, P van Voorst Vader, and H Young
IUSTI: 2008 European Guidelines on the Management of Syphilis
Int J STD AIDS, May 1, 2009; 20(5): 300 - 309.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
A. E. Singh and B. Romanowski
Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features
Clin. Microbiol. Rev., April 1, 1999; 12(2): 187 - 209.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
D. M. Musher, R. J. Hamill, and R. E. Baughn
Effect of Human Immunodeficiency Virus (HIV) Infection on the Course of Syphilis and on the Response to Treatment
Ann Intern Med, December 1, 1990; 113(11): 872 - 881.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
H.-W. Pfister, V. Preac-Mursic, B. Wilske, and K. M. Einhaupl
Cefotaxime vs Penicillin G for Acute Neurologic Manifestations in Lyme Borreliosis: A Prospective Randomized Study
Arch Neurol, November 1, 1989; 46(11): 1190 - 1194.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.